We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PKBK:NASDAQParke Bancorp, Inc. Analysis

Data as of 2026-06-08 - not real-time

$31.19

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Parke Bancorp (PKBK) is trading at $31.19, well below its DCF‑derived fair value of $93.71, indicating substantial upside. The stock’s trailing P/E of 8.9 is less than half the industry average of 17, reinforcing the undervaluation thesis. Revenue surged 35% year‑over‑year and profit margins exceed 50%, underscoring strong growth momentum. A dividend yield of 2.31% combined with a modest 20.6% payout ratio suggests the dividend is comfortably sustainable. The balance sheet shows ample cash ($111 M) relative to debt, and a low beta of 0.66 points to defensive price behavior. Overall, the fundamentals paint a picture of a value‑oriented growth story.
Technically, the price sits above the 20‑day SMA (30.75) and the 50‑day SMA (30.06), confirming a bullish trend despite a slightly bearish MACD histogram. RSI at 57 is neutral, and the stock is trading near the $29.83 support level with $32.43 as the next resistance. The recent board‑approved stock repurchase program adds a catalyst that could tighten supply and support price appreciation. Volatility over the past 30 days is moderate at 16%, and volume remains stable, indicating reasonable liquidity. Given the confluence of attractive valuation, solid earnings, and a supportive corporate action, PKBK appears positioned for upside across horizons.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • stock repurchase program boosting demand
  • price trading above short‑term SMA and below resistance
  • attractive dividend yield with low payout ratio

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • undervalued relative to DCF and industry peers
  • strong earnings margins and 35% revenue growth
  • stable cash flow supporting dividend and buybacks

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • significant upside to DCF fair value
  • consistent profitability and solid capital position
  • low beta and defensive banking sector exposure

Key Metrics & Analysis

Financial Health

Revenue Growth35.30%
Profit Margin50.21%
P/E Ratio8.9
ROE13.05%
ROA1.92%
P/B Ratio1.1
Op. Cash Flow$45.6M
Industry P/E17.0

Technical Analysis

TrendBullish
RSI57.6
Support$29.83
Resistance$32.43
MA 20$30.75
MA 50$30.06
MA 200$25.71
MACDBearish
VolumeStable
Fear & Greed Index83.02

Valuation

Fair Value$93.71
GradeUndervalued
TypeBlend
Dividend Yield2.31%

Risk Assessment

Beta0.67
Volatility16.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.